Allicock, Orchid M.
Yolda-Carr, Devyn
Todd, John A.
Wyllie, Anne L.
Funding for this research was provided by:
Fast Grants
Flambeau Diagnostics
Article History
Received: 11 April 2022
Accepted: 5 May 2023
First Online: 8 May 2023
Competing interests
: John Todd serves on the Board of Directors of SalivaDirect, Inc. Anne Wyllie has received consulting and/or advisory board fees from Pfizer, RADx, Diasorin, PPS Health, Co-Diagnostics, Filtration Group, and Global Diagnostic Systems for work unrelated to this project, is Principal Investigator on research grants with Pfizer and Merck to Yale University and serves on the Board of Directors of SalivaDirect, Inc. Orchid Allicock and Devyn Yolda-Carr declare no competing interests.